Non-CME Product Showcase
Discussion of Brukinsa™ For Adult Patients With Mantle Cell Lymphoma (MCL) Who Have Received At Least One Prior Therapy
September 25, 2020
11:45 AM EDT
Join us for a valuable discussion on the trial data for newly-approved BRUKINSATM in mantle cell lymphoma (MCL), as well as a review of it’s dosage and administration. Healthcare professionals including hematologist oncologists, medical oncologists, pharmacists, PAs, NPs, and RNs are encouraged to participate in this valuable dialogue.
Speaker: Lori Leslie, MD, Director, indolent lymphoma and CLL research programs, John Theurer Cancer Center
Please RSVP to Carl Majeski at 570-793-6034 or email [email protected].
Click here to enter the Non-CME Product Showcase Presentation.
Dial In Number: 888-788-0099
Meeting ID: 942 5659 6841
Passcode: 690028
Click here to view the Non-CME Product Show Case Flyer and to learn more about Brukinsa™
September 25, 2020
11:45 AM EDT
Join us for a valuable discussion on the trial data for newly-approved BRUKINSATM in mantle cell lymphoma (MCL), as well as a review of it’s dosage and administration. Healthcare professionals including hematologist oncologists, medical oncologists, pharmacists, PAs, NPs, and RNs are encouraged to participate in this valuable dialogue.
Speaker: Lori Leslie, MD, Director, indolent lymphoma and CLL research programs, John Theurer Cancer Center
Please RSVP to Carl Majeski at 570-793-6034 or email [email protected].
Click here to enter the Non-CME Product Showcase Presentation.
Dial In Number: 888-788-0099
Meeting ID: 942 5659 6841
Passcode: 690028
Click here to view the Non-CME Product Show Case Flyer and to learn more about Brukinsa™
